Plasma membrane proteomics and its application in clinical cancer biomarker discovery

Molecular and Cellular Proteomics

Volumn 9, Issue 7, 2010, Pages 1369-1382

  Leth Larsen, Rikke ^a   Lund, Rikke R ^a   Ditzel, Henrik J ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL SURFACE PROTEIN; MEMBRANE PROTEIN; PROTEOME; TUMOR MARKER;

CANCER CELL; CANCER SURVIVAL; CELL FRACTIONATION; CELL MEMBRANE; CELL SURFACE; DRUG TARGETING; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW; CHEMISTRY; METABOLISM; NEOPLASMS; PROCEDURES; PROTEIN PROCESSING;

CELL MEMBRANE; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954730167     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.R900006-MCP200     Document Type: Review

References (178)

1. Mouritsen, O. G., and Bloom, M. (1993) Models of lipid-protein interactions in membranes. Annu. Rev. Biophys. Biomol. Struct. 22, 145-171
2. Mukherjee, S., and Maxfield, F. R. (2004) Membrane domains. Annu. Rev. Cell Dev. Biol. 20, 839-866
3. Guidotti, G. (1972) Membrane proteins. Annu. Rev. Biochem. 41, 731-752
4. Bretscher, M. S., and Raff, M. C. (1975) Mammalian plasma membranes. Nature 258, 43-49
5. Zheng, Y. Z., and Foster, L. J. (2009) Biochemical and proteomic approaches for the study of membrane microdomains. J. Proteomics 72, 12-22
6. Escribá, P. V., Gonzá lez-Ros, J. M., Goñi, F. M., Kinnunen, P. K., Vigh, L., Sánchez-Magraner, L., Fernández, A. M., Busquets, X., Horváth, I., and Barceló-Coblijn, G. (2008) Membranes: a meeting point for lipids, proteins and therapies. J. Cell. Mol. Med. 12, 829-875
7. Kabbani, N. (2008) Proteomics of membrane receptors and signaling. Proteomics 8, 4146-4155
8. Patwardhan, A. J., Strittmatter, E. F., Camp, D. G., 2nd, Smith, R. D., and Pallavicini, M. G. (2005) Comparison of normal and breast cancer cell lines using proteome, genome, and interactome data. J. Proteome Res. 4, 1952-1960
9. Cox, J., and Mann, M. (2007) Is proteomics the new genomics? Cell 130, 395-398 (Pubitemid 47198310)
10. Krogh, A., Larsson, B., von Heijne, G., and Sonnhammer, E. L. L. (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305, 567-580 (Pubitemid 33032862)
11. Wallin, E., and von Heijne, G. (1998) Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci. 7, 1029-1038 (Pubitemid 28216544)
12. Pike, L. J. (2009) The challenge of lipid rafts. J. Lipid Res. 50, S323-328
13. Harvey, S., Zhang, Y., Landry, F., Miller, C., and Smith, J. W. (2001) Insights into a plasma membrane signature. Physiol. Genomics 5, 129-136
14. Landry, Y., and Gies, J. P. (2008) Drugs and their molecular targets: an updated overview. Fundam. Clin. Pharmacol. 22, 1-18 (Pubitemid 351171284)
15. Dorsam, R. T., and Gutkind, J. S. (2007) G-protein-coupled receptors and cancer. Nat. Rev. Cancer 7, 79-94
16. Gschwind, A., Fischer, O. M., and Ullrich, A. (2004) The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 4, 361-370 (Pubitemid 38579482)
17. Swanton, C., Futreal, A., and Eisen, T. (2006) Her2-targeted therapies in non-small cell lung cancer. Clin. Cancer Res. 12, 4377s-4383s
18. Qiu, H., and Wang, Y. (2008) Quantitative analysis of surface plasma membrane proteins of primary and metastatic melanoma cells. J. proteome Res. 7, 1904-1915
19. Aggelis, V., Craven, R. A., Peng, J., Harnden, P., Cairns, D. A., Maher, E. R., Tonge, R., Selby, P. J., and Banks, R. E. (2009) Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model. Proteomics 9, 2118-2130
20. Gou, L. T., Tong, A. P., Chen, L. J., Tang, M. H., Chen, B., Liang, S. F., Huang, C., and Wei, Y. Q. (2008) Comparative plasma membrane-associated proteomics of immortalized human hepatocytes. Biochemistry 73, 1200-1206
21. Conn, E. M., Madsen, M. A., Cravatt, B. F., Ruf, W., Deryugina, E. I., and Quigley, J. P. (2008) Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation. J. Biol. Chem. 283, 26518-26527
22. Leth-Larsen, R., Lund, R., Hansen, H. V., Laenkholm, A. V., Tarin, D., Jensen, O. N., and Ditzel, H. J. (2009) Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol. Cell. Proteomics 8, 1436-1449
23. Liang, X., Zhao, J., Hajivandi, M., Wu, R., Tao, J., Amshey, J. W., and Pope, R. M. (2006) Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma. J. proteome Res. 5, 2632-2641 (Pubitemid 44595165)
24. Falleni, M., Pellegrini, C., Marchetti, A., Oprandi, B., Buttitta, F., Barassi, F., Santambrogio, L., Coggi, G., and Bosari, S. (2003) Survivin gene expression in early-stage non-small cell lung cancer. J. Pathol. 200, 620-626 (Pubitemid 36987311)
25. Simpson, A. J., Caballero, O. L., Jungbluth, A., Chen, Y. T., and Old, L. J. (2005) Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 5, 615-625
26. Larsen, M. R., Trelle, M. B., Thingholm, T. E., and Jensen, O. N. (2006) Analysis of posttranslational modifications of proteins by tandem mass spectrometry. BioTechniques 40, 790-798 (Pubitemid 46534920)
27. Jensen, O. N. (2006) Interpreting the protein language using proteomics. Nat. Rev. Mol. Cell Biol. 7, 391-403
28. Apweiler, R., Hermjakob, H., and Sharon, N. (1999) On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1473, 4-8
29. Fuster, M. M., and Esko, J. D. (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 5, 526-542
30. Lehmann, F., Tiralongo, E., and Tiralongo, J. (2006) Sialic acid-specific lectins: occurrence, specificity and function. Cell. Mol. Life Sci. 63, 1331-1354 (Pubitemid 43939016)
31. Blomme, B., Van Steenkiste, C., Callewaert, N., and Van Vlierberghe, H. (2009) Alteration of protein glycosylation in liver diseases. J. Hepatol. 50, 592-603
32. Kim, Y. J., and Varki, A. (1997) Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj. J. 14, 569-576
33. Seales, E. C., Jurado, G. A., Brunson, B. A., Wakefield, J. K., Frost, A. R., and Bellis, S. L. (2005) Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by upregulating cell motility. Cancer Res. 65, 4645-4652
34. Hedlund, M., Ng, E., Varki, A., and Varki, N. M. (2008) alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res. 68, 388-394 (Pubitemid 351380065)
35. Varki, N. M., and Varki, A. (2007) Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab. Invest. 87, 851-857
36. Dube, D. H., and Bertozzi, C. R. (2005) Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4, 477-488
37. Peracaula, R., Barrabés, S., Sarrats, A., Rudd, P. M., and de Llorens, R. (2008) Altered glycosylation in tumours focused to cancer diagnosis. Dis. Markers 25, 207-218
38. Block, T. M., Comunale, M. A., Lowman, M., Steel, L. F., Romano, P. R., Fimmel, C., Tennant, B. C., London, W. T., Evans, A. A., Blumberg, B. S., Dwek, R. A., Mattu, T. S., and Mehta, A. S. (2005) Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. U.S.A. 102, 779-784 (Pubitemid 40282742)
39. Ohyama, C. (2008) Glycosylation in bladder cancer. Int. J. Clin. Oncol. 13, 308-313
40. Hägglund, P., Bunkenborg, J., Elortza, F., Jensen, O. N., and Roepstorff, P. (2004) A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J. Proteome Res. 3, 556-566 (Pubitemid 39207360)
41. Taylor, A. D., Hancock, W. S., Hincapie, M., Taniguchi, N., and Hanash, S. M. (2009) Towards an integrated proteomic and glycomic approach to finding cancer biomarkers. Genome Med. 1, 57
42. Mechref, Y., Hussein, A., Bekesova, S., Pungpapong, V., Zhang, M., Dobrolecki, L. E., Hickey, R. J., Hammoud, Z. T., and Novotny, M. V. (2009) Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease. J. Proteome Res. 8, 2656-2666
43. Ito, H., Kuno, A., Sawaki, H., Sogabe, M., Ozaki, H., Tanaka, Y., Mizokami, M., Shoda, J., Angata, T., Sato, T., Hirabayashi, J., Ikehara, Y., and Narimatsu, H. (2009) Strategy for glycoproteomics: identification of glyco-alteration using multiple glycan profiling tools. J. Proteome Res. 8, 1358-1367
44. Vercoutter-Edouart, A. S., Slomianny, M. C., Dekeyzer-Beseme, O., Haeuw, J. F., and Michalski, J. C. (2008) Glycoproteomics and glycomics investigation of membrane N-glycosylproteins from human colon carcinoma cells. Proteomics 8, 3236-3256
45. Larsen, M. R., Jensen, S. S., Jakobsen, L. A., and Heegaard, N. H. (2007) Exploring the sialiome using titanium dioxide chromatography and mass spectrometry. Mol. Cell. Proteomics 6, 1778-1787 (Pubitemid 350031679)
46. Goetz, J. A., Mechref, Y., Kang, P., Jeng, M. H., and Novotny, M. V. (2009) Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconj. J. 26, 117-131
47. Kyselova, Z., Mechref, Y., Kang, P., Goetz, J. A., Dobrolecki, L. E., Sledge, G. W., Schnaper, L., Hickey, R. J., Malkas, L. H., and Novotny, M. V. (2008) Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin. Chem. 54, 1166-1175 (Pubitemid 352009693)
48. Arnold, J. N., Saldova, R., Hamid, U. M., and Rudd, P. M. (2008) Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8, 3284-3293
49. Wang, Y., Ao, X., Vuong, H., Konanur, M., Miller, F. R., Goodison, S., and Lubman, D. M. (2008) Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach. J. Proteome Res. 7, 4313-4325
50. Selby, D. S., Larsen, M. R., Calvano, C. D., and Jensen, O. N. (2008) Identification and characterization of N-glycosylated proteins using proteomics. Methods Mol. Biol. 484, 263-276
51. Hollingsworth, M. A., and Swanson, B. J. (2004) Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4, 45-60
52. Burchell, J. M., Mungul, A., and Taylor-Papadimitriou, J. (2001) O-Linked glycosylation in the mammary gland: changes that occur during malignancy. J. Mammary Gland Biol. Neoplasia 6, 355-364
53. Sangha, R., and Butts, C. (2007) L-BLP25: a peptide vaccine strategy in non small cell lung cancer. Clin. Cancer Res. 13, s4652-4654
54. Perkins, G. L., Slater, E. D., Sanders, G. K., and Prichard, J. G. (2003) Serum tumor markers. Am. Fam. Physician 68, 1075-1082
55. Shariat, S. F., Karam, J. A., Margulis, V., and Karakiewicz, P. I. (2008) New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer. BJU Int. 101, 675-683
56. Chong, P. K., Lee, H., Kong, J. W., Loh, M. C., Wong, C. H., and Lim, Y. P. (2008) Phosphoproteomics, oncogenic signaling and cancer research. Proteomics 8, 4370-4382
57. Sefton, B. M., and Shenolikar, S. (2001) Overview of protein phosphorylation. Curr. Protoc. Protein Sci. Chapter 13, Unit 13.1
58. Thingholm, T. E., Jensen, O. N., and Larsen, M. R. (2009) Analytical strategies for phosphoproteomics. Proteomics 9, 1451-1468
59. Castellvi, J., Garcia, A., Ruiz-Marcellan, C., Hernández-Losa, J., Peg, V., Salcedo, M., Gil-Moreno, A., and Ramon y Cajal, S. (2009) Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum. Pathol. 40, 1418-1426
60. McArdle, L., Rafferty, M., Maelandsmo, G. M., Bergin, O., Farr, C. J., Dervan, P. A., O'Loughlin, S., Herlyn, M., and Easty, D. J. (2001) Protein tyrosine phosphatase genes downregulated in melanoma. J. Invest. Dermatol. 117, 1255-1260
61. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225
62. Ashman, K., and Villar, E. L. (2009) Phosphoproteomics and cancer research. Clin. Transl. Oncol. 11, 356-362
63. Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P., and Jørgensen, T. J. (2005) Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics 4, 873-886
64. Scaltriti, M., Verma, C., Guzman, M., Jimenez, J., Parra, J. L., Pedersen, K., Smith, D. J., Landolfi, S., Ramon y Cajal, S., Arribas, J., and Baselga, J. (2009) Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity. Oncogene 28, 803-814
65. Capdevila, J., Elez, E., Macarulla, T., Ramos, F. J., Ruiz-Echarri, M., and Tabernero, J. (2009) Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Cancer Treat. Rev. 35, 354-363
66. Moran, M. F., Tong, J., Taylor, P., and Ewing, R. M. (2006) Emerging applications for phospho-proteomics in cancer molecular therapeutics. Biochim. Biophys. Acta 1766, 230-241
67. Chambers, A. F., Groom, A. C., and MacDonald, I. C. (2002) Metastasis: Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572
68. Dowling, P., Walsh, N., and Clynes, M. (2008) Membrane and membrane-associated proteins involved in the aggressive phenotype displayed by highly invasive cancer cells. Proteomics 8, 4054-4065
69. Bidard, F. C., Pierga, J. Y., Vincent-Salomon, A., and Poupon, M. F. (2008) A "class action" against the microenvironment: do cancer cells cooperate in metastasis? Cancer Metastasis Rev. 27, 5-10
70. Hood, J. D., and Cheresh, D. A. (2002) Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91-100 (Pubitemid 37328796)
71. Lund, R., Leth-Larsen, R., Jensen, O. N., and Ditzel, H. J. (2009) Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers. J. Proteome Res. 8, 3078-3090
72. Chen, R., Yi, E. C., Donohoe, S., Pan, S., Eng, J., Cooke, K., Crispin, D. A., Lane, Z., Goodlett, D. R., Bronner, M. P., Aebersold, R., and Brentnall, T. A. (2005) Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology 129, 1187-1197
73. Kischel, P., Guillonneau, F., Dumont, B., Bellahcène, A., Stresing, V., Clézardin, P., De Pauw, E. A., and Castronovo, V. (2008) Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells. Neoplasia 10, 1014-1020
74. Garbis, S., Lubec, G., and Fountoulakis, M. (2005) Limitations of current proteomics technologies. J. Chromatogr. A 1077, 1-18
75. Zhao, Y., Zhang, W., Kho, Y., and Zhao, Y. (2004) Proteomic analysis of integral plasma membrane proteins. Anal. Chem. 76, 1817-1823 (Pubitemid 38451494)
76. Blonder, J., Goshe, M. B., Moore, R. J., Pasa-Tolic, L., Masselon, C. D., Lipton, M. S., and Smith, R. D. (2002) Enrichment of integral membrane proteins for proteomic analysis using liquid chromatography and tandem mass spectrometry. J. Proteome Res. 1, 351-360 (Pubitemid 36395876)
77. Josic, D., and Clifton, J. G. (2007) Mammalian plasma membrane proteomics. Proteomics 7, 3010-3029
78. Kristensen, D. B., Brønd, J. C., Nielsen, P. A., Andersen, J. R., Sørensen, O. T., Jørgensen, V., Budin, K., Matthiesen, J., Venø, P., Jespersen, H. M., Ahrens, C. H., Schandorff, S., Ruhoff, P. T., Wisniewski, J. R., Bennett, K. L., and Podtelejnikov, A. V. (2004) Experimental Peptide Identification Repository (EPIR): an integrated peptide-centric platform for validation and mining of tandem mass spectrometry data. Mol. Cell. Proteomics 3, 1023-1038
79. Mannová, P., Fang, R., Wang, H., Deng, B., McIntosh, M. W., Hanash, S. M., and Beretta, L. (2006) Modification of host lipid raft proteome upon hepatitis C virus replication. Mol. Cell. Proteomics 5, 2319-2325 (Pubitemid 46040636)
80. Bartee, E., McCormack, A., and Früh, K. (2006) Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2, e107
81. Righetti, P. G., Castagna, A., Antonioli, P., and Boschetti, E. (2005) Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 26, 297-319 (Pubitemid 40253785)
82. Hör, S., Ziv, T., Admon, A., and Lehner, P. J. (2009) Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase. Mol. Cell. Proteomics 8, 1959-1971
83. Rahbar, A. M., and Fenselau, C. (2005) Unbiased examination of changes in plasma membrane proteins in drug resistant cancer cells. J. Proteome Res. 4, 2148-2153
84. Vargo-Gogola, T., and Rosen, J. M. (2007) Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer 7, 659-672 (Pubitemid 47327411)
85. Chen, E. I., and Yates, J. R., 3rd (2007) Cancer proteomics by quantitative shotgun proteomics. Mol. Oncol. 1, 144-159
86. Lacroix, M., and Leclercq, G. (2004) Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res. Treat. 83, 249-289 (Pubitemid 38264873)
87. Celis, J. E., Moreira, J. M., Cabezón, T., Gromov, P., Friis, E., Rank, F., and Gromova, I. (2005) Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell. Proteomics 4, 492-522
88. Hwang, S. I., Thumar, J., Lundgren, D. H., Rezaul, K., Mayya, V., Wu, L., Eng, J., Wright, M. E., and Han, D. K. (2007) Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues. Oncogene 26, 65-76
89. Kim, J., Kim, S. H., Lee, S. U., Ha, G. H., Kang, D. G., Ha, N. Y., Ahn, J. S., Cho, H. Y., Kang, S. J., Lee, Y. J., Hong, S. C., Ha, W. S., Bae, J. M., Lee, C. W., and Kim, J. W. (2002) Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 23, 4142-4156
90. Niméus, E., Malmström, J., Johnsson, A., Marko-Varga, G., and Fernö, M. (2007) Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy. J. Pharm. Biomed. Anal. 43, 1086-1093
91. Hood, B. L., Darfler, M. M., Guiel, T. G., Furusato, B., Lucas, D. A., Ringeisen, B. R., Sesterhenn, I. A., Conrads, T. P., Veenstra, T. D., and Krizman, D. B. (2005) Proteomic analysis of formalin-fixed prostate cancer tissue. Mol. Cell. Proteomics 4, 1741-1753 (Pubitemid 41749267)
92. Schmitt, M., Mengele, K., Schueren, E., Sweep, F. C., Foekens, J. A., Brünner, N., Laabs, J., Malik, A., and Harbeck, N. (2007) European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group standard operating procedure for the preparation of human tumour tissue extracts suited for the quantitative analysis of tissue-associated biomarkers. Eur. J. Cancer 43, 835-844
93. Nielsen, P. A., Olsen, J. V., Podtelejnikov, A. V., Andersen, J. R., Mann, M., and Wisniewski, J. R. (2005) Proteomic mapping of brain plasma membrane proteins. Mol. Cell. Proteomics 4, 402-408 (Pubitemid 40590560)
94. Conrotto, P., Roesli, C., Rybak, J., Kischel, P., Waltregny, D., Neri, D., and Castronovo, V. (2008) Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. Int. J. Cancer 123, 2856-2864
95. Clarke, W., Zhang, Z., and Chan, D. W. (2003) The application of clinical proteomics to cancer and other diseases. Clin. Chem. Lab. Med. 41, 1562-1570 (Pubitemid 38055006)
96. Diaz, J. I., Cazares, L. H., and Semmes, O. J. (2008) Tissue sample collection for proteomics analysis. Methods Mol. Biol. 428, 43-53
97. Rai, A. J., Gelfand, C. A., Haywood, B. C., Warunek, D. J., Yi, J., Schuchard, M. D., Mehigh, R. J., Cockrill, S. L., Scott, G. B., Tammen, H., Schulz-Knappe, P., Speicher, D. W., Vitzthum, F., Haab, B. B., Siest, G., and Chan, D. W. (2005) HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262-3277
98. Pieragostino, D., Petrucci, F., Del Boccio, P., Mantini, D., Lugaresi, A., Tiberio, S., Onofrj, M., Gambi, D., Sacchetta, P., Di Ilio, C., Federici, G., and Urbani, A. (2010) Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. J. Proteomics 73, 579-592
99. Hondermarck, H., Tastet, C., El Yazidi-Belkoura, I., Toillon, R. A., and Le Bourhis, X. (2008) Proteomics of breast cancer: the quest for markers and therapeutic targets. J. Proteome Res. 7, 1403-1411
100. Patel, V., Hood, B. L., Molinolo, A. A., Lee, N. H., Conrads, T. P., Braisted, J. C., Krizman, D. B., Veenstra, T. D., and Gutkind, J. S. (2008) Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin. Cancer Res. 14, 1002-1014 (Pubitemid 351302545)
101. Neubauer, H., Clare, S. E., Wozny, W., Schwall, G. P., Poznanovic, S., Stegmann, W., Vogel, U., Sotlar, K., Wallwiener, D., Kurek, R., Fehm, T., and Cahill, M. A. (2008) Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1. Breast Cancer Res. 10, R85
102. Sprung, R. W., Jr., Brock, J. W., Tanksley, J. P., Li, M., Washington, M. K., Slebos, R. J., and Liebler, D. C. (2009) Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. Mol. Cell. Proteomics 8, 1988-1998
103. Paradela, A., and Albar, J. P. (2008) Advances in the analysis of protein phosphorylation. J. Proteome Res. 7, 1809-1818
104. Tissot, B., North, S. J., Ceroni, A., Pang, P. C., Panico, M., Rosati, F., Capone, A., Haslam, S. M., Dell, A., and Morris, H. R. (2009) Glycoproteomics: past, present and future. FEBS Lett. 583, 1728-1735
105. Dalpathado, D. S., and Desaire, H. (2008) Glycopeptide analysis by mass spectrometry. Analyst 133, 731-738
106. Cho, W., Jung, K., and Regnier, F. E. (2008) Use of glycan targeting antibodies to identify cancer-associated glycoproteins in plasma of breast cancer patients. Anal. Chem. 80, 5286-5292
107. Jung, K., Cho, W., and Regnier, F. E. (2009) Glycoproteomics of plasma based on narrow selectivity lectin affinity chromatography. J. Proteome Res. 8, 643-650
108. Powlesland, A. S., Hitchen, P. G., Parry, S., Graham, S. A., Barrio, M. M., Elola, M. T., Mordoh, J., Dell, A., Drickamer, K., and Taylor, M. E. (2009) Targeted glycoproteomic identification of cancer cell glycosylation. Glycobiology 19, 899-909
109. Yang, Z., and Hancock, W. S. (2005) Monitoring glycosylation pattern changes of glycoproteins using multi-lectin affinity chromatography. J. Chromatogr. A 1070, 57-64 (Pubitemid 40417767)
110. Drake, R. R., Schwegler, E. E., Malik, G., Diaz, J., Block, T., Mehta, A., and Semmes, O. J. (2006) Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol. Cell. Proteomics 5, 1957-1967 (Pubitemid 44688203)
111. Wuhrer, M., Koeleman, C. A., Hokke, C. H., and Deelder, A. M. (2005) Protein glycosylation analyzed by normal-phase nano-liquid chromatography-mass spectrometry of glycopeptides. Anal. Chem. 77, 886-894
112. Koizumi, K. (1996) High-performance liquid chromatographic separation of carbohydrates on graphitized carbon columns. J. Chromatogr. A 720, 119-126
113. Harvey, D. J. (2005) Proteomic analysis of glycosylation: structural determination of N- and O-linked glycans by mass spectrometry. Expert Rev. Proteomics 2, 87-101
114. Kirmiz, C., Li, B., An, H. J., Clowers, B. H., Chew, H. K., Lam, K. S., Ferrige, A., Alecio, R., Borowsky, A. D., Sulaimon, S., Lebrilla, C. B., and Miyamoto, S. (2007) A serum glycomics approach to breast cancer biomarkers. Mol. Cell. Proteomics 6, 43-55
115. Zhang, H., Loriaux, P., Eng, J., Campbell, D., Keller, A., Moss, P., Bonneau, R., Zhang, N., Zhou, Y., Wollscheid, B., Cooke, K., Yi, E. C., Lee, H., Peskind, E. R., Zhang, J., Smith, R. D., and Aebersold, R. (2006) UniPep - a database for human N-linked glycosites: a resource for biomarker discovery. Genome Biol. 7, R73 (Pubitemid 44468851)
116. Cordwell, S. J., and Thingholm, T. E. (2010) Technologies for plasma membrane proteomics. Proteomics 10, 611-627
117. Zarling, A. L., Polefrone, J. M., Evans, A. M., Mikesh, L. M., Shabanowitz, J., Lewis, S. T., Engelhard, V. H., and Hunt, D. F. (2006) Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. Proc. Natl. Acad. Sci. U.S.A. 103, 14889-14894 (Pubitemid 44527824)
118. Kim, J. E., and White, F. M. (2006) Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells. J. Immunol. 176, 2833-2843
119. Wolf-Yadlin, A., Hautaniemi, S., Lauffenburger, D. A., and White, F. M. (2007) Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. U.S.A. 104, 5860-5865 (Pubitemid 47175624)
120. Alcolea, M. P., Kleiner, O., and Cutillas, P. R. (2009) Increased confidence in large-scale phosphoproteomics data by complementary mass spectrometric techniques and matching of phosphopeptide data sets. J. Proteome Res. 8, 3808-3815
121. Thingholm, T. E., Jensen, O. N., Robinson, P. J., and Larsen, M. R. (2008) SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol. Cell. Proteomics 7, 661-671
122. Thingholm, T. E., Larsen, M. R., Ingrell, C. R., Kassem, M., and Jensen, O. N. (2008) TiO(2)-based phosphoproteomic analysis of the plasma membrane and the effects of phosphatase inhibitor treatment. J. Proteome Res. 7, 3304-3313
123. Zhao, Y., Lee, W. N., and Xiao, G. G. (2009) Quantitative proteomics and biomarker discovery in human cancer. Expert Rev. Proteomics 6, 115-118
124. Hanash, S. M., Pitteri, S. J., and Faca, V. M. (2008) Mining the plasma proteome for cancer biomarkers. Nature 452, 571-579
125. Foster, L. J., Zeemann, P. A., Li, C., Mann, M., Jensen, O. N., and Kassem, M. (2005) Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 23, 1367-1377 (Pubitemid 41504924)
126. Van Hoof, D., Dormeyer, W., Braam, S. R., Passier, R., Monshouwer-Kloots, J., Ward-van Oostwaard, D., Heck, A. J., Krijgsveld, J., and Mummery, C. L. (2010) Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J. Proteome Res. 9, 1610-1618
127. Mann, M. (2006) Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 7, 952-958
128. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999 (Pubitemid 29474856)
129. Li, J., Steen, H., and Gygi, S. P. (2003) Protein profiling with cleavable isotope-coded affinity tag (cICAT) reagents: the yeast salinity stress response. Mol. Cell. Proteomics 2, 1198-1204
130. Butler, G. S., Dean, R. A., Tam, E. M., and Overall, C. M. (2008) Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Mol. Cell. Biol. 28, 4896-4914
131. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
132. Yao, X., Freas, A., Ramirez, J., Demirev, P. A., and Fenselau, C. (2001) Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal. Chem. 73, 2836-2842 (Pubitemid 32868136)
133. Zieske, L. R. (2006) A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J. Exp. Bot. 57, 1501-1508
134. Ramus, C., Gonzalez de Peredo, A., Dahout, C., Gallagher, M., and Garin, J. (2006) An optimized strategy for ICAT quantification of membrane proteins. Mol. Cell. Proteomics 5, 68-78 (Pubitemid 43169342)
135. Pawlik, T. M., Hawke, D. H., Liu, Y., Krishnamurthy, S., Fritsche, H., Hunt, K. K., and Kuerer, H. M. (2006) Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 6, 68
136. Han, C. L., Chien, C. W., Chen, W. C., Chen, Y. R., Wu, C. P., Li, H., and Chen, Y. J. (2008) A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease. Mol. Cell. Proteomics 7, 1983-1997
137. Rajcevic, U., Petersen, K., Knol, J. C., Loos, M., Bougnaud, S., Klychnikov, O., Li, K. W., Pham, T. V., Wang, J., Miletic, H., Peng, Z., Bjerkvig, R., Jimenez, C. R., and Niclou, S. P. (2009) iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype. Mol. Cell. Proteomics 8, 2595-2612
138. Ho, J., Kong, J. W., Choong, L. Y., Loh, M. C., Toy, W., Chong, P. K., Wong, C. H., Wong, C. Y., Shah, N., and Lim, Y. P. (2009) Novel breast cancer metastasis-associated proteins. J. Proteome Res. 8, 583-594
139. Ye, X., Luke, B., Andresson, T., and Blonder, J. (2009) 18O stable isotope labeling in MS-based proteomics. Brief. Funct. Genomic. Proteomic. 8, 136-144
140. Kristiansen, T. Z., Harsha, H. C., Grønborg, M., Maitra, A., and Pandey, A. (2008) Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma. J. Proteome Res. 7, 4670-4677
141. Chi, L. M., Lee, C. W., Chang, K. P., Hao, S. P., Lee, H. M., Liang, Y., Hsueh, C., Yu, C. J., Lee, I. N., Chang, Y. J., Lee, S. Y., Yeh, Y. M., Chang, Y. S., Chien, K. Y., and Yu, J. S. (2009) Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS. Mol. Cell. Proteomics 8, 1453-1474
142. Stockwin, L. H., Blonder, J., Bumke, M. A., Lucas, D. A., Chan, K. C., Conrads, T. P., Issaq, H. J., Veenstra, T. D., Newton, D. L., and Rybak, S. M. (2006) Proteomic analysis of plasma membrane from hypoxia-adapted malignant melanoma. J. Proteome Res. 5, 2996-3007 (Pubitemid 44749218)
143. Röwer, C., Vissers, J. P., Koy, C., Kipping, M., Hecker, M., Reimer, T., Gerber, B., Thiesen, H. J., and Glocker, M. O. (2009) Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue. Anal. Bioanal. Chem. 395, 2443-2456
144. Zhu, Z., Boobis, A. R., and Edwards, R. J. (2008) Identification of estrogen-responsive proteins in MCF-7 human breast cancer cells using label-free quantitative proteomics. Proteomics 8, 1987-2005 (Pubitemid 351775779)
145. Ishihama, Y., Sato, T., Tabata, T., Miyamoto, N., Sagane, K., Nagasu, T., and Oda, Y. (2005) Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Nat. Biotechnol. 23, 617-621 (Pubitemid 41724902)
146. Sihlbom, C., Wilhelmsson, U., Li, L., Nilsson, C. L., and Pekny, M. (2007) 14-3-3 expression in denervated hippocampus after entorhinal cortex lesion assessed by culture-derived isotope tags in quantitative proteomics. J. Proteome Res. 6, 3491-3500
147. Rasmussen, N., and Ditzel, H. J. (2009) Scanning the cell surface proteome of cancer cells and identification of metastasis-associated proteins using a subtractive immunization strategy. J. Proteome Res. 8, 5048-5059
148. Giltnane, J. M., and Rimm, D. L. (2004) Technology insight: Identification of biomarkers with tissue microarray technology. Nat. Clin. Pract. Oncol. 1, 104-111
149. Thomson, T. A., Zhou, C., Chu, C., and Knight, B. (2009) Tissue microarray for routine analysis of breast biomarkers in the clinical laboratory. Am. J. Clin. Pathol. 132, 899-905
150. Mager, S. R., Oomen, M. H., Morente, M. M., Ratcliffe, C., Knox, K., Kerr, D. J., Pezzella, F., and Riegman, P. H. (2007) Standard operating
151. Wasielewski, R., Hasselmann, S., Rüschoff, J., Fisseler-Eckhoff, A., and Kreipe, H. (2008) Proficiency testing of immunohistochemical biomarker assays in breast cancer. Virchows Arch. 453, 537-543
152. Camp, R. L., Chung, G. G., and Rimm, D. L. (2002) Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat. Med. 8, 1323-1327
153. Rubin, M. A., Zerkowski, M. P., Camp, R. L., Kuefer, R., Hofer, M. D., Chinnaiyan, A. M., and Rimm, D. L. (2004) Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA race-mase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements. Am. J. Pathol. 164, 831-840
154. Harigopal, M., Heymann, J., Ghosh, S., Anagnostou, V., Camp, R. L., and Rimm, D. L. (2009) Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome. Breast Cancer Res. Treat. 115, 77-85
155. Kozarova, A., Petrinac, S., Ali, A., and Hudson, J. W. (2006) Array of informatics: applications in modern research. J. Proteome Res. 5, 1051-1059
156. Sanchez-Carbayo, M. (2006) Antibody arrays: technical considerations and clinical applications in cancer. Clin. Chem. 52, 1651-1659
157. MacBeath, G. (2002) Protein microarrays and proteomics. Nat. Genet. 32, (suppl.) 526-532
158. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., and Gygi, S. P. (2003) Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U.S.A. 100, 6940-6945
159. Pratt, J. M., Simpson, D. M., Doherty, M. K., Rivers, J., Gaskell, S. J., and Beynon, R. J. (2006) Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nat. Protoc. 1, 1029-1043
160. Mirzaei, H., McBee, J. K., Watts, J., and Aebersold, R. (2008) Comparative evaluation of current peptide production platforms used in absolute quantification in proteomics. Mol. Cell. Proteomics 7, 813-823
161. Zucker, S., Hymowitz, M., Conner, C., Zarrabi, H. M., Hurewitz, A. N., Matrisian, L., Boyd, D., Nicolson, G., and Montana, S. (1999) Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues: clinical and experimental applications. Ann. N. Y. Acad. Sci. 878, 212-227
162. Anderson, N. L., and Anderson, N. G. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867
163. Pardo, M., García, A., Antrobus, R., Blanco, M. J., Dwek, R. A., and Zitzmann, N. (2007) Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum. J. Proteome Res. 6, 2802-2811
164. Whelan, S. A., Lu, M., He, J., Yan, W., Saxton, R. E., Faull, K. F., Whitelegge, J. P., and Chang, H. R. (2009) Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers. J. Proteome Res. 8, 4151-4160
165. Gross, M., Top, I., Laux, I., Katz, J., Curran, J., Tindell, C., and Agus, D. (2007) Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer. Clin. Cancer Res. 13, 1979-1986 (Pubitemid 46649863)
166. Souder, C., Leitzel, K., Ali, S. M., Demers, L., Evans, D. B., Chaudri-Ross, H. A., Hackl, W., Hamer, P., Carney, W., and Lipton, A. (2006) Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer. Cancer 107, 2337-2345 (Pubitemid 44753823)
167. Sandri, M. T., Johansson, H. A., Zorzino, L., Salvatici, M., Passerini, R., Maisonneuve, P., Rocca, A., Peruzzotti, G., and Colleoni, M. (2007) Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy. Cancer 110, 509-517 (Pubitemid 47106138)
168. Witzel, I., Thomssen, C., Krenkel, S., Wilczak, W., Bubenheim, M., Pantel, K., Neumann, R., Jänicke, F., and Müller, V. (2006) Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer. Int. J. Biol. Markers 21, 131-140 (Pubitemid 44660284)
169. Ali, S. M., Carney, W. P., Esteva, F. J., Fornier, M., Harris, L., Köstler, W. J., Lotz, J. P., Luftner, D., Pichon, M. F., and Lipton, A. (2008) Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer. Cancer 113, 1294-1301
170. Mayer, S., zur Hausen, A., Watermann, D. O., Stamm, S., Jäger, M., Gitsch, G., and Stickeler, E. (2008) Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients. J. Cancer Res. Clin. Oncol. 134, 1229-1235
171. Lim, K. T., Miyazaki, K., Kimura, N., Izawa, M., and Kannagi, R. (2008) Clinical application of functional glycoproteomics - dissection of glycotopes carried by soluble CD44 variants in sera of patients with cancers. Proteomics 8, 3263-3273
172. Callesen, A. K., Vach, W., Jørgensen, P. E., Cold, S., Tan, Q., Depont Christensen, R., Mogensen, O., Kruse, T. A., Jensen, O. N., and Madsen, J. S. (2008) Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study. J. Proteome Res. 7, 1419-1426
173. Becker, S., Cazares, L. H., Watson, P., Lynch, H., Semmes, O. J., Drake, R. R., and Laronga, C. (2004) Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann. Surg. Oncol. 11, 907-914 (Pubitemid 40486676)
174. Vlahou, A., Laronga, C., Wilson, L., Gregory, B., Fournier, K., McGaughey, D., Perry, R. R., Wright, G. L., Jr., and Semmes, O. J. (2003) A novel approach toward development of a rapid blood test for breast cancer. Clin. Breast Cancer 4, 203-209 (Pubitemid 37185057)
175. Knoop, A. S., Bentzen, S. M., Nielsen, M. M., Rasmussen, B. B., and Rose, C. (2001) Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients. J. Clin. Oncol. 19, 3376-3384
176. Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351, 1451-1467
177. Early Breast Cancer Trialists' Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365, 1687-1717
178. Umar, A., Kang, H., Timmermans, A. M., Look, M. P., Meijer-van Gelder, M. E., den Bakker, M. A., Jaitly, N., Martens, J. W., Luider, T. M., Foekens, J. A., and Pasa-Toliæ, L. (2009) Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer. Mol. Cell. Proteomics 8, 1278-1294